Fungal x host interactions in Chromoblastomycosis

References

• Medlar EM. A cutaneous infection caused by a new fungus, Phialophora verrucosa, with a study of the fungus. J Med Res 1915; 32:506
   Google Scholar
• Pedroso A, Gomes JM. Sobre quatro casos de dermatite verrucosa produzidos por Phialophora verrucosa. An Paul Med Cir 1920; 11:53 - 61
   Google Scholar
• Simson WF, Harrington C, Barnetson J. Chromoblastomycosis: a report of six cases. J Path Bact 1943; 45:191 - 198
   Google Scholar
• Azulay RD. Experimental studyes on chromoblastomycosis. J Invest Dermatol 1945; 6:281 - 292
   PubMed Web of Science ®Google Scholar
• Gomes JM, Pessoa S. Reprodução experimental de dermatite verrucosa. Brasil Medico 1929; 43:255 - 257
   Google Scholar
• Simpson JG. A case of chromoblastomycosis in a horse. Vet Med Small Anim Clin 1966; 61:1207 - 1209
   PubMedGoogle Scholar
• Buckley HR, Murray IG. Precipitating antibodies in chromomycosis. Sabouraudia 1966; 5:78 - 80
   PubMedGoogle Scholar
• Velasquez LF, Restrepo A. Chromomycosis in the toad (Bufo marinus) and a comparison of the etiologic agent with fungi causing human chromomycosis. Sabouraudia 1975; 13:1 - 9
   PubMedGoogle Scholar
• Kurita N. Cell-mediated immune responses in mice infected with Fonsecaea pedrosoi. Mycopathologia 1979; 68:9 - 15
   PubMed Web of Science ®Google Scholar
• Ibrahim-Granet O, de Bievre C, Jendoubi M. Immunochemical characterization of antigens and growth inhibition of Fonsecaea pedrosoi by species-specific IgG. J Med Microbiol 1988; 26:217 - 222
   PubMed Web of Science ®Google Scholar
• Tsuneto LT, Arce-Gomez B, Petzl-Erler ML, Queiroz-Telles F. HLA-A29 and genetic susceptibility to chromoblastomycosis. J Med Vet Mycol 1989; 27:181 - 185
   PubMedGoogle Scholar
• Yegres F. Cromomicosis por Cladosporium carrionii en criadores de caprinos del estado Fálcon. Investigacíon Clínica 1985; 26:235 - 246
   Web of Science ®Google Scholar
• Ahrens J, Graybill JR, Abishawl A, Tio FO, Rinaldi MG. Experimental murine chromomycosis mimicking chronic progressive human disease. Am J Trop Med Hyg 1989; 40:651 - 658
   PubMed Web of Science ®Google Scholar
• Esterre P, Lortat-Jacob H, Sainte-Marie D, Pradinaud R, Grimaud JA. The potential role of cytokines in the immunopathology of chromoblastomycosis. J Mycol Méd 1994; 4:145 - 148
   Google Scholar
• Rozental S, Alviano CS, de Souza W. The in vitro susceptibility of Fonsecaea pedrosoi to activated macrophages. Mycopathologia 1994; 126:85 - 91
   PubMed Web of Science ®Google Scholar
• d'Avila SC, Pagliari C, Duarte MI. The cell-mediated immune reaction in the cutaneous lesion of chromoblastomycosis and their correlation with different clinical forms of the disease. Mycopathologia 2003; 156:51 - 60
   PubMed Web of Science ®Google Scholar
• Alviano DS, Franzen AJ, Travassos LR, Holandino C, Rozental S, Ejzemberg R, et al. Melanin from Fonsecaea pedrosoi induces production of human antifungal antibodies and enhances the antimicrobial efficacy of phagocytes. Infect Immun 2004; 72:229 - 237
   PubMed Web of Science ®Google Scholar
• Mazo FGV, Da Gloria DS, Ferreira KS, Marques SG, Goncalves AG, Vagner de Castro Lima Santos, et al. Cytokines and lymphocyte proliferation in patients with different clinical forms of chromoblastomycosis. Microbes Infect 2005; 7:708 - 713
   PubMed Web of Science ®Google Scholar
• Teixeira de Sousa MG, Ghosn EE, Almeida SR. Absence of CD4+ T cells impairs host defence of mice infected with Fonsecaea pedrosoi. Scand J Immunol 2006; 64:595 - 600
   PubMed Web of Science ®Google Scholar
• Najafzadeh MJ, Gueidan C, Badali H, Van Den Ende AH, Xi L, De Hoog GS. Genetic diversity and species delimitation in the opportunistic genus Fonsecaea. Med Mycol 2009; 47:17 - 25
   PubMed Web of Science ®Google Scholar
• Salgado CG, da Silva JP, Diniz JA, da Silva MB, da Costa PF, Teixeira C, et al. Isolation of Fonsecaea pedrosoi from thorns of Mimosa pudica, a probable natural source of chromoblastomycosis. Rev Inst Med Trop Sao Paulo 2004; 46:33 - 36
   PubMedGoogle Scholar
• Salgado CG, da Silva JP, da Silva MB, da Costa PF, Salgado UI. Cutaneous diffuse chromoblastomycosis. Lancet Infect Dis 2005; 5:528
   PubMed Web of Science ®Google Scholar
• Salgado CG, da Silva MB, Yamano SS, Salgado UI, Diniz JA, da Silva JP. Cutaneous localized annular chromoblastomycosis. J Cutan Pathol 2009; 36:257 - 261
   PubMed Web of Science ®Google Scholar
• da Silva MB, da Silva JP, Sirleide Pereira YS, Salgado UI, Diniz JA, Salgado CG. Development of natural culture media for rapid induction of Fonsecaea pedrosoi sclerotic cells in vitro. J Clin Microbiol 2008; 46:3839 - 3841
   PubMed Web of Science ®Google Scholar
• da Silva JP, da Silva MB, Salgado UI, Diniz JA, Rozental S, Salgado CG. Phagocytosis of Fonsecaea pedrosoi conidia, but not sclerotic cells caused by Langerhans cells, inhibits CD40 and B7-2 expression. FEMS Immunol Med Microbiol 2007; 50:104 - 111
   PubMed Web of Science ®Google Scholar
• Machado AP, Silva MRR, Fischman O. Prolonged infection by Fonsecaea pedrosoi after antigenic costimulation at different sites in experimental murine chromoblastomycosis. Virulence 2010; 1:29 - 36
   PubMed Web of Science ®Google Scholar